📰 Lb Pharmaceuticals News
Lb Pharmaceuticals News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Lb Pharmaceuticals. Real-time updates on events, politics, business and more.
May 12, 2022
/PRNewswire/ -- Curative Biotechnology Inc. (OTC: CUBT) ("Curative Biotech" or the "Company"), a development-stage biomedical company focused on novel...
April 11, 2022
Hospitalized COVID patients over 65 were three times as likely to receive a dementia diagnosis if they took psychiatric drugs.
October 4, 2021
NEW YORK--(BUSINESS WIRE)--#BrainHealth--LB Pharmaceuticals Inc, (“LB”) a biotechnology company focused on developing and commercializing novel and improved versions of successful CNS treatments, announced today that results of PET studies of its lead compound to treat schizophrenia, LB-102, have been presented at t...
February 3, 2021
Search jobs 02-Feb-2021 LB Pharmaceuticals Announces the Initiation of Patient Dosing in Open Label Phase 1b Imaging Study of LB-102 NEW YORK--(BUSINESS WIRE)--#LB102--LB Pharmaceuticals Inc, (“LB”) a biotechnology company focused on developing and commercializing novel and improved versions of successful CNS treatments, announced today the administration of the first dose of LB-102 in a Phase 1b clinical trial (Clinical Trials Identifier NCT0458...